Primary Endpoint: Mean Change in A1C From Baseline at 30 Weeks<sup>1</sup>

Accordion title open

Show Description

Accordion title close

Close Description

Primary Endpoint: Mean Change in A1C From Baseline at 30 Weeks¹

A bar chart showing the mean change in A1C from baseline at 30 weeks for Mounjaro vs placebo. The mean baseline A1C was 8.0%. Mounjaro 5 mg (n=32) had a 1.9 percent reduction from baseline; Mounjaro 10 mg (n=33) had a 2.2 percent reduction from baseline; pooled Mounjaro (5 mg and 10 mg) (n=65) had a 2.0 percent reduction from baseline; and placebo (n=34) had a 0.2 percent reduction from baseline.

Primary Endpoint: Mean Change in A1C From Baseline at 30 Weeks1

Primary Endpoint: Mean Change in A1C From Baseline at 30 Weeks¹